We offer a number of solutions to medication adherence. The financial cost to non-adherence includes:
- Increased hospitalizations
- Higher insurance costs
- Losses to insurance carriers
- Lower prescription refills
Existing apps let the user claim they took medication or snooze the schedule dose for later. Guardian Clinical™ requires the user access the medication container. By getting the patient “off the couch,” we dramatically improve adherence.
Mobile Application – Guardian Clinical™
Guardian Clinical™ for iOS and Android is the end-user software that schedules, notifies, and tracks medication adherence by users. Unlike task apps that permit users to self-report they took the medication, Guardian requires the physical scanning of the medication container. By bringing the patient to the medication, we dramatically enhance adherence.
Web-Portal for Clinical Trials and Medical Practice
For clinical trials and medical professionals seeking higher adherence rates, Guardian Portal is a web-based application that gives detailed information to medical professionals at their fingertips. Data from the mobile app is accessible, sorted and exportable to extrinsic datastores.
For Clinical Studies
Hundreds of millions are lost in failed clinical studies due to non-adherence. Valuable and effective therapies are potentially rejected by regulators due to the non-adherence of the test subjects. Used in combination with the mobile app, Guardian Portal provides enhanced dose verification including exact time, GPS location and other metrics which are exportable for support of the trial validity. Self-reporting is not enough. Guardian Portal can establish both adherence and non-adherence in subjects to better gauge and support efficacy of new therapeutics.
Medicare and Medicaid
The CDC published findings in 2019:
…population-level annual estimates demonstrated that avoidable health care costs resulted in $4.5 billion for nonadherent older adults with diabetes, $5.6 billion for those with heart failure, and $5.1 billion for those with hyperlipidemia. In addition, there would be 117,594https://www.cdc.gov/dhdsp/pubs/docs/sib_july2019-508.pdf (retrieved Jan. 20, 2022)
fewer emergency department (ED) visits and at least 7 million fewer inpatient hospital days if nonadherent beneficiaries with hypertension became adherent; if just 25% of nonadherent Medicare FFS beneficiaries with hypertension became adherent, Medicare could save $13.7 million per year.